China · Delayed Price · Currency is CNY Newland Pharmaceutical Statistics
Total Valuation
SHE:301277 has a market cap or net worth of CNY 4.68 billion. The enterprise value is 3.97 billion.
| Market Cap | 4.68B |
| Enterprise Value | 3.97B |
Important Dates
The last earnings date was Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | Apr 16, 2025 |
Share Statistics
SHE:301277 has 392.08 million shares outstanding. The number of shares has decreased by -0.88% in one year.
| Current Share Class | 392.08M |
| Shares Outstanding | 392.08M |
| Shares Change (YoY) | -0.88% |
| Shares Change (QoQ) | -1.91% |
| Owned by Insiders (%) | 63.76% |
| Owned by Institutions (%) | 0.31% |
| Float | 98.88M |
Valuation Ratios
The trailing PE ratio is 38.52.
| PE Ratio | 38.52 |
| Forward PE | n/a |
| PS Ratio | 6.96 |
| PB Ratio | 3.02 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | 301.02 |
| P/OCF Ratio | 40.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.73, with an EV/FCF ratio of 255.16.
| EV / Earnings | 32.73 |
| EV / Sales | 5.90 |
| EV / EBITDA | 22.73 |
| EV / EBIT | 33.21 |
| EV / FCF | 255.16 |
Financial Position
The company has a current ratio of 6.26, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.26 |
| Quick Ratio | 5.81 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.37 |
| Interest Coverage | 563.69 |
Financial Efficiency
Return on equity (ROE) is 7.76% and return on invested capital (ROIC) is 12.96%.
| Return on Equity (ROE) | 7.76% |
| Return on Assets (ROA) | 4.16% |
| Return on Invested Capital (ROIC) | 12.96% |
| Return on Capital Employed (ROCE) | 7.43% |
| Weighted Average Cost of Capital (WACC) | 6.70% |
| Revenue Per Employee | 645,277 |
| Profits Per Employee | 116,361 |
| Employee Count | 1,042 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 7.62 |
Taxes
In the past 12 months, SHE:301277 has paid 14.06 million in taxes.
| Income Tax | 14.06M |
| Effective Tax Rate | 10.48% |
Stock Price Statistics
The stock price has increased by +10.15% in the last 52 weeks. The beta is 0.45, so SHE:301277's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +10.15% |
| 50-Day Moving Average | 12.36 |
| 200-Day Moving Average | 13.29 |
| Relative Strength Index (RSI) | 54.29 |
| Average Volume (20 Days) | 3,663,941 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301277 had revenue of CNY 672.38 million and earned 121.25 million in profits. Earnings per share was 0.31.
| Revenue | 672.38M |
| Gross Profit | 225.14M |
| Operating Income | 119.49M |
| Pretax Income | 134.12M |
| Net Income | 121.25M |
| EBITDA | 172.06M |
| EBIT | 119.49M |
| Earnings Per Share (EPS) | 0.31 |
Balance Sheet
The company has 718.55 million in cash and 5.69 million in debt, with a net cash position of 712.86 million or 1.82 per share.
| Cash & Cash Equivalents | 718.55M |
| Total Debt | 5.69M |
| Net Cash | 712.86M |
| Net Cash Per Share | 1.82 |
| Equity (Book Value) | 1.55B |
| Book Value Per Share | 3.96 |
| Working Capital | 896.33M |
Cash Flow
In the last 12 months, operating cash flow was 116.94 million and capital expenditures -101.38 million, giving a free cash flow of 15.55 million.
| Operating Cash Flow | 116.94M |
| Capital Expenditures | -101.38M |
| Depreciation & Amortization | 52.57M |
| Net Borrowing | -1.80M |
| Free Cash Flow | 15.55M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 33.48%, with operating and profit margins of 17.77% and 18.03%.
| Gross Margin | 33.48% |
| Operating Margin | 17.77% |
| Pretax Margin | 19.95% |
| Profit Margin | 18.03% |
| EBITDA Margin | 25.59% |
| EBIT Margin | 17.77% |
| FCF Margin | 2.31% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.62%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.62% |
| Dividend Growth (YoY) | 40.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 92.39% |
| Buyback Yield | 0.88% |
| Shareholder Yield | 2.52% |
| Earnings Yield | 2.59% |
| FCF Yield | 0.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 16, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Apr 16, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHE:301277 has an Altman Z-Score of 14.98 and a Piotroski F-Score of 4.
| Altman Z-Score | 14.98 |
| Piotroski F-Score | 4 |